Medical devices, healthcare technology and the business of care
PMA approval · P020018

ZENITH AAA ENDOVASCULAR GRAFT AND H&L-B ONE-SHOT INTRODUCTINO SYSTEM

Cook, Inc. · Decision date May 23, 2003

MEDTECHLEDGER EXPLANATIONP020018

What did the FDA approve?

The FDA database entry records an original PMA approval dated May 23, 2003, for the Zenith AAA Endovascular Graft and H&L-B One-Shot Introduction System from Cook, Inc. The decision field is APPR, and the statement describes approval for the device as indicated for endovascular treatment of patients with abdominal aortic or aorto-iliac aneurysms having morphology suitable for endovascular repair.

The entry does not include supplement type or supplement reason, so no later modification to the original approval is described. The statement reports the approved indication language but does not itself provide independent evidence of safety or clinical effectiveness. Specific information absent from the record includes any clinical trial data, labeling details beyond the quoted indication, and manufacturing or design-change history.

FDA approval order statement

APPROVAL FOR THE ZENITH AAA ENDOVASCULAR GRAFT AND H&L-B ONE-SHOT INTRODUCTION SYSTEM. THE DEVICE IS INDICATED FOR THE ENDOVASCULAR TREATMENT OF PATIENTS WITH ABDOMINAL AORTIC OR AORTO-ILIAC ANEURYSMS HAVING MORPHOLOGY SUITABLE FOR ENDOVASCULAR REPAIR.
Regulatory pathway
Original PMA
Clinical specialty
Cardiovascular
Decision date
May 23, 2003

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P020018
Regulatory pathway
Premarket approval application
Applicant
Cook, Inc.
Product code
MIH
Decision code
APPR
Decision date
May 23, 2003
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT.

Applicant
Cook, Inc.
Product code
MIH
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P020018 received

    Application receipt date recorded by FDA.

  2. P020018 · FDA decision

    APPR

  3. P020018/S070 · Related supplement

    Zenith Fenestrated AAA Endovascular Graft, Zenith Iliac Branch

Timeline entries are records held by MedtechLedger for P020018. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P020018

Product / regulatory recordCompanyPathwayDecision dateSource
Cook, Inc.PMA supplementSep 17, 2026FDA

Explore the linked device profile

Other records with product code MIH

Product / regulatory recordCompanyPathwayDecision dateSource
Bolton Medical, Inc.PMA supplementOct 28, 2026FDA
Bolton Medical, Inc.PMA approvalAug 5, 2021FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Cook, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
750 Daniels Way, P.O. Box 489, Bloomington, IN, 47402

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records